Trials / Completed
CompletedNCT03296956
A Dietary Supplement for Mood Symptoms in Early Postpartum: A Double Blind Randomized Placebo Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- Centre for Addiction and Mental Health · Academic / Other
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine whether a dietary supplement (DS) is effective in protecting against sad mood in postpartum as compared to placebo.
Detailed description
This double blind placebo controlled randomized trial will evaluate the effect of administration of a dietary supplement (DS) on the intensity of postpartum blues. It is expected that the administration will result in less sadness in day-5 postpartum women after negative mood induction in those receiving the dietary supplement compared to placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Motherwell | The interventions involves a dietary supplement called Motherwell, at current stage, to reduce the intensity of sadness in day-5 postpartum women. |
| OTHER | Placebo | Matching placebo for appearance, taste |
Timeline
- Start date
- 2018-12-01
- Primary completion
- 2022-12-25
- Completion
- 2023-06-20
- First posted
- 2017-09-29
- Last updated
- 2023-10-05
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT03296956. Inclusion in this directory is not an endorsement.